In attempting to ensure that the pharmaceutical industry is able to function profitably, and perhaps, efficiently, policy-makers have completely ignored the health concerns that are integrally linked to the contours of the drug policy.
To continue reading, become a subscriber.
Explore our attractive subscription offers.
Click here
